Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers [clinicaltrials:NCT00005762]
Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers [clinicaltrials:NCT00005762]
Bio2RDF identifier
NCT00005762
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00005762
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... lerance
of these drugs.
brief title [clinicaltrials_vocabulary:brief-title]
Drug Interactions of Amprenavi ...... or, in HIV-Negative Volunteers
completion date [clinicaltrials_vocabulary:completion-date]
2004-05-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Triple-drug antiretrovi ...... and urine and blood sampling.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2000-05-25T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Anti-HIV Agents
Dosage Forms
Drug Interactions
Drug Therapy, Combination
HIV Protease Inhibitors
Nelfinavir
Pharmacokinetics
Saquinavir
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2013-07-19T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00005762
official title [clinicaltrials_vocabulary:official-title]
Pharmacokinetic Interaction St ...... in HIV-Seronegative Volunteers
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2001-03-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2013-07-01T00:00:00Z
identifier
clinicaltrials:NCT00005762
title
Drug Interactions of Amprenavi ...... or, in HIV-Negative Volunteers
@en
type
label
Drug Interactions of Amprenavi ...... s [clinicaltrials:NCT00005762]
@en